The closing price of Terns Pharmaceuticals Inc (NASDAQ: TERN) was $7.20 for the day, up 7.30% from the previous closing price of $6.71. In other words, the price has increased by $+0.49 from its previous closing price. On the day, 666266 shares were traded.
Ratios:
Our analysis of TERN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 22.39 and its Current Ratio is at 22.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on June 22, 2023, initiated with a Buy rating and assigned the stock a target price of $16.
On June 07, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $18.
On May 31, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $23.ROTH MKM initiated its Buy rating on May 31, 2023, with a $23 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 465.49M and an Enterprise Value of 202.66M. Its current Enterprise Value per Revenue stands at 337.47 whereas that against EBITDA is -1.99.
Stock Price History:
Over the past 52 weeks, TERN has reached a high of $14.04, while it has fallen to a 52-week low of $3.26. The 50-Day Moving Average of the stock is 6.57, while the 200-Day Moving Average is calculated to be 6.58.
Shares Statistics:
TERN traded an average of 773.88K shares per day over the past three months and 1.61M shares per day over the past ten days. A total of 64.58M shares are outstanding, with a floating share count of 39.66M. Insiders hold about 38.66% of the company’s shares, while institutions hold 76.31% stake in the company. Shares short for TERN as of Feb 29, 2024 were 4.38M with a Short Ratio of 5.66, compared to 4.24M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.09% and a Short% of Float of 10.92%.
Earnings Estimates
The firm’s stock currently is rated by 8 analysts. On average, analysts expect EPS of -$0.33 for the current quarter, with a high estimate of -$0.27 and a low estimate of -$0.38, while EPS last year was -$0.31. The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.29 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$1.1 and -$1.56 for the fiscal current year, implying an average EPS of -$1.37. EPS for the following year is -$1.37, with 7 analysts recommending between -$0.98 and -$1.86.
